UnicoCell Biomed Co., Ltd. (TPE:6794)

UnicoCell Biomed Revenue

UnicoCell Biomed had revenue of 6.28M TWD in the quarter ending March 31, 2026, a decrease of -36.24%. This brings the company's revenue in the last twelve months to 26.54M, down -32.07% year-over-year. In the year 2025, UnicoCell Biomed had annual revenue of 30.10M, down -5.58%.

• Revenue (ttm): 26.54M
• Revenue Growth: -32.07%
• P/S Ratio: 191.62
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 5.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	30.10M	-1.78M	-5.58%
Dec 31, 2024	31.88M	7.29M	29.66%
Dec 31, 2023	24.59M	10.19M	70.79%
Dec 31, 2022	14.40M	6.22M	76.07%
Dec 31, 2021	8.18M	4.20M	105.35%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error